P.D. Hinduja Hospital & MRC introduces latest innovation in IV Infusion – ET HealthWorld

Mumbai: P.D. Hinduja Hospital & Medical Research Centre, Mahim introduces the latest Innovation in IV Infusion to focus its efforts and create awareness around the increasing trend and effective management of antimicrobial resistance (AMR).

The World Health Organization (WHO) has declared AMR as one of the top 10 global health threats facing humanity. India has one of the highest rates of AMR in the world, and according to government data released in 2019 these infections claim lives of close to 7,00,000 Indians annually.

“Stakeholders across India are working together to combat the alarming rate of antimicrobial resistance (AMR). While all precautions are taken, this challenge frequently extends beyond basic hospital hygiene and is rapidly becoming a global health concern. Adopting antimicrobial stewardship is a critical component of this, and one of the first steps that must be taken is to raise awareness and understanding of AMR through effective communication,” said, Joy Chakraborty, Chief Operating Officer, P.D Hinduja Hospital & MRC.

“The government of India has taken several measures to control the rise of AMR in India, we look forward to partnering with stakeholders like P.D. Hinduja Hospital & MRC to reduce this burden by increasing access to this innovative technology for advanced care. Uniport is a first-of-its-kind closed IV technology platform that is being manufactured by Amneal for India, in India. The INICC (International Nosocomial Infection Control Consortium), recommends the use of closed infusion systems for the administration of clinical treatments in hospitals,” said Shyamakant Giri, Managing Director & President, India Business and Emerging Markets, Amneal Healthcare.